Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration

J Microbiol Immunol Infect. 2021 Apr;54(2):276-283. doi: 10.1016/j.jmii.2019.07.004. Epub 2019 Aug 6.

Abstract

Background: Clostridium difficile is the leading cause of nosocomial infectious diarrhea. Hospitalized patients were at risk of C. difficile-associated diarrhea (CDAD). However the risk factors of CDAD in patients with different hospitalization period are not clear.

Material and methods: A prospective investigation was conducted in medical wards of a district hospital in southern Taiwan, from January 2011 to January 2013. We arbitrary divided patients into two groups: hospitalized for at most 14 days and 15-30 days, and analyzed their risk factors for CDAD.

Results: Overall 451 patients were enrolled. The multivariable analysis of 19 (8.0%) patients developing CDAD within 14 days' hospital stay and 216 patients hospitalized for ≤ 14 days without CDAD showed malignancy (odds ratio [OR] 7.15, 95% confidence interval [CI] 1.82-28.09; P = 0.005), prior cephalosporin (OR 10.8, 95% CI 1.3-93.9; P = 0.03) and proton pump inhibitor (PPI; OR 7.1, 95% CI 2.1-24.7; P = 0.002) therapy were independently related to CDAD (Table 3), but hypertension (OR 0.2, 95% CI 0.1-0.7; P = 0.01) was reversely related to CDAD. However, of 9 (4.2%) patients developing CDAD later (15-30 days' hospital stay) and 207 patients with longer hospitalization (15-30 days) but free of CDAD, malignancy (OR 14.0, 95% CI 1.6-124.9; P = 0.02) and underlying diabetes mellitus (OR 20.5, 95% CI 2.9-144.9; P = 0.002) were independent risk factors of CDAD.

Conclusion: Risk factors for CDAD among hospitalized patients varied by the duration of hospital stay. Intervention strategies to prevent CDAD may be different in terms of hospital stay duration.

Keywords: Cephalosporin; Clostridium difficile; Diabetes mellitus; Malignancy; Prolonged hospitalization; Proton pump inhibitors.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Cephalosporins
  • Clostridioides difficile*
  • Clostridium Infections / drug therapy
  • Clostridium Infections / epidemiology*
  • Clostridium Infections / microbiology*
  • Cross Infection / microbiology
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / microbiology
  • Diarrhea / drug therapy
  • Diarrhea / microbiology*
  • Female
  • Hospitalization*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Neoplasms
  • Odds Ratio
  • Prospective Studies
  • Proton Pump Inhibitors / therapeutic use
  • Risk Factors
  • Taiwan / epidemiology

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Proton Pump Inhibitors